Connect with us

Uncategorized

The Evolving Urban Office Landscape

The office market is still struggling with high interest rates and high levels of remote work, producing a tough lending environment and frozen deals on…

Published

on

The office market is still struggling with high interest rates and high levels of remote work, producing a tough lending environment and frozen deals on the sales side, and generous concessions and terms that favor tenants on the leasing side.

In tech hubs like Seattle, the market has been getting worse. That said, there are glimmers of hope, according to office experts at NAIOP’s CRE. Converge 2023 in Seattle.

On the panel were moderator Phil Mobley, national director, U.S. Office Analytics for CoStar Group, Inc.; Todd Battison, senior vice president and shareholder, Kidder Matthews; and Jason Flynn, CFA, managing director, Eastdil Secured.

The panelists said the office market has been evolving post-pandemic as companies figure out how they plan to use office space. Unlike downturns and upswings in the market, the office sector is likely seeing a permanent change in companies’ office usage. How it all shakes out is not yet clear, but traditional office does have future, they say.

“One important point here from talking to other professionals is that we’re not just talking about a cyclical downturn, we’re talking about a paradigm shift, how people value the office, how often they come in the office,” said Battison.

This sorting-out period is affecting all aspects of the market, from how tenants evaluate their leases and space needs, the values, and how lenders and investors react to new project proposals and sales deals.

“From my perspective in dealing with trying to sell finance assets and get capital there [to a deal], it’s really a function of utilization and how do you underwrite that demand going forward,” Flynn said. Flynn pointed to how tech companies are adding employees but shedding space in offices significantly.

“So, the question is, are they just not coming to the office or are they building the space out differently? And I think that from my perspective, that story is still playing out.”

Mobley kicked off the session with three trends in office noticed by Costar analysts. Firstly, office usage by companies is down to about 60% compared to the pre-pandemic norm, and that figure has been stable since the beginning of the year. Secondly and surprisingly, he said, office jobs fully recovered after 20 months rather than the six years they took after the Great Recession. And thirdly, he said, the growth of office employment has slowed down this year.

“Interestingly and paradoxically, there are at least as many active tenants in the market as there were, they’re just taking less space,” Mobley said.

“So, if you talk to brokers, which I do all the time, they’ll say, ‘Oh, we’re busy and there’s a lot of activity in the market and they’re right,” Mobley said. “It’s just that those tenants are taking less space, they’re renewing with lower frequency … that’s actually causing a shrinkage of overall demand and occupancy in the market even though there is activity.”

The leasing side remains grim on many levels. Tenants have the upper hand in deals and are demanding discounts off the face rate and usually want generous concessions, like a month’s free rent in every year of the lease term, Battison said. Tenants are looking for high-quality buildings with amenities and away from urban problems, such as crime and homelessness. This means that outdated buildings in sketchier areas will likely struggle.

“We’re seeing lease packages, like 19 months of free rent on an 11-year deal with $150 in tenant improvements for a big deal,” Battison said. “It plugs a hole in a building. I just came to agreement on a small 5,000-square-foot deal yesterday with 12 months of free rent for a 65-month term.”

Not all is grim on the leasing and sales side. Flynn noted that several large companies, such as Roblox and Nike, have recently called back workers to the office or increased the number of required office days.

On the sales side, while the market had been frozen on the West Coast for months, activity is picking up again, particularly in San Francisco.

“San Francisco is kind of leading us out of that and maybe it’s because it was kind of feeling the pain earlier and maybe it’s because it’s got this international gateway city reputation,” Flynn said. “But in San Francisco there have been 12 deals this year.  Six have closed, four are in contract and two are bidding in real time.”

Panelists noted that sales prices have been impaired, partly driven by high interest rates. Mobley said the peak-to-trough decline is roughly 30%, but some cash or low-leverage buyers of assets valued at $15 million or less – which is a type of office building that is still trading – are getting a 60% or 70% discount.

Despite the sector’s struggles and uncertainty, Flynn believes these issues are largely cyclical and the sector will rebound.

“I don’t believe that office … is done,” he said. “It is too important, I think, to the overall corporate strategy and I think the CEOs are learning that as they go along.”


JLL logo

This post is brought to you by JLL, the social media and conference blog sponsor of NAIOP’s CRE.Converge 2023. Learn more about JLL at www.us.jll.com or www.jll.ca.

Read More

Continue Reading

Uncategorized

Why do some men not produce sperm?

KANSAS CITY, MO—October 20, 2023—Millions of couples worldwide experience infertility with half of the cases originating in men. For 10% of infertile…

Published

on

KANSAS CITY, MO—October 20, 2023—Millions of couples worldwide experience infertility with half of the cases originating in men. For 10% of infertile males, little or no sperm are produced. Now, new research from the Stowers Institute for Medical Research, in collaboration with the Wellcome Centre for Cell Biology at the University of Edinburgh, is shedding light on what may be going wrong in the process of sperm formation, leading to potential theories on possible treatments.  

Credit: Stowers Institute for Medical Research

KANSAS CITY, MO—October 20, 2023—Millions of couples worldwide experience infertility with half of the cases originating in men. For 10% of infertile males, little or no sperm are produced. Now, new research from the Stowers Institute for Medical Research, in collaboration with the Wellcome Centre for Cell Biology at the University of Edinburgh, is shedding light on what may be going wrong in the process of sperm formation, leading to potential theories on possible treatments.  

“A significant cause of infertility in males is that they just cannot make sperm,” said Stowers Investigator Scott Hawley, Ph.D. “If you know exactly what is wrong, there are technologies emerging right now that might give you a way to fix it.”  

The study published on October 20, 2023, in Science Advances from the Hawley Lab and Wellcome Centre Investigator Owen Davies, Ph.D., may help explain why some men do not make enough sperm to fertilize an egg. In most sexually reproducing species, including humans, a critical protein structure resembling a lattice-like bridge needs to be built properly to produce sperm and egg cells. The team led by former Postdoctoral Research Associate Katherine Billmyre, Ph.D., discovered that in mice, changing a single and very specific point in this bridge caused it to collapse, leading to infertility and thus providing insight into human infertility in males due to similar problems with meiosis. 

Meiosis, the cell division process giving rise to sperm and eggs, involves several steps, one of which is the formation of a large protein structure called the synaptonemal complex. Like a bridge, the complex holds chromosome pairs in place enabling necessary genetic exchanges to occur that are essential for the chromosomes to then correctly separate into sperm and eggs.  

“A significant contributor to infertility is defects in meiosis,” said Billmyre. “To understand how chromosomes separate into reproductive cells correctly, we are really interested in what happens right before that when the synaptonemal complex forms between them.”  

Previous studies have examined many proteins comprising the synaptonemal complex, how they interact with each other, and have identified various mutations linked to male infertility. The protein the researchers investigated in this study forms the lattices of the proverbial bridge, which has a section found in humans, mice, and most other vertebrates suggesting it is critical for assembly. Modeling different mutations in a potentially crucial region in the human protein enabled the team to predict which of these might disrupt protein function. 

The authors used a precise gene editing technique to make mutations in one key synaptonemal complex protein in mice, which allowed the researchers, for the first time, to test the function of key regions of the protein in live animals. Just a single mutation, predicted from the modeling experiments, was verified as the culprit of infertility in mice.   

“We’re talking about pinpoint surgery here,” said Hawley. “We focused on a tiny little region of one protein in this gigantic structure that we were pretty sure could be a significant cause of infertility.”  

Mice have long been used as models for human diseases. From the modeling experiments using human protein sequences, along with the high conservation of this protein structure across species, the precise molecule that caused infertility in mice likely functions the same way in humans.   

“What is really exciting to me is that our research can help us understand this really basic process that is necessary for life,” said Billmyre.  

For Hawley, this research is a true representation of the versatility of the Institute. Hawley’s lab typically conducts research in fruit flies, yet the protein discovered in this study was not present in fruit flies and demanded a different research organism to continue. Because of the resources and Technology Centers at the Institute, it was possible to quickly pivot and test the new infertility hypothesis in mice. 

“I can’t imagine another place where this could happen,” said Hawley. “I think it’s an amazing example of how the Stowers Institute’s dedication toward discovery can yield big results providing important leaps forward in understanding.”     

Additional authors include Emily A. Kesler, Dai Tsuchiya, Ph.D., Timothy J. Corbin, Kyle Weaver, Andrea Moran, Zulin Yu, Ph.D., Lane Adams, Kym Delventhal, Michael Durnin, Ph.D., and Owen Richard Davies, Ph.D. 

This work was funded by the Wellcome Centre for Cell Biology (award: 203149), the Wellcome Senior Research Fellowship (award: 219413/Z/19/Z), and by institutional support from the Stowers Institute for Medical Research.  

About the Stowers Institute for Medical Research 

Founded in 1994 through the generosity of Jim Stowers, founder of American Century Investments, and his wife, Virginia, the Stowers Institute for Medical Research is a non-profit, biomedical research organization with a focus on foundational research. Its mission is to expand our understanding of the secrets of life and improve life’s quality through innovative approaches to the causes, treatment, and prevention of diseases. 

The Institute consists of 20 independent research programs. Of the approximately 500 members, over 370 are scientific staff that include principal investigators, technology center directors, postdoctoral scientists, graduate students, and technical support staff. Learn more about the Institute at www.stowers.org and about its graduate program at www.stowers.org/gradschool. 

Media Contact: 

Joe Chiodo, Head of Media Relations 
724.462.8529 
press@stowers.org 


Read More

Continue Reading

Uncategorized

Penny Stocks To Buy? Watch These 3 Under $5 Before Next Week

Penny stocks have not been as popular as you might think over…
The post Penny Stocks To Buy? Watch These 3 Under $5 Before Next Week appeared first on…

Published

on

Penny stocks have not been as popular as you might think over the last few weeks. Thanks to plenty of economic uncertainty and concerns over inflation, investors have pulled back on risk. However, that doesn’t mean traders are dealing the same.

Anyone who’s swing trading, day trading, or scalping is loving this type of volatility in the stock market today. Is that a big pullback in the SPY? Who cares as long as you know how to find the best penny stocks to buy, right?

Of course, it’s easier said than done. But it is possible all the same and it is happening daily. Even with the stock market down today, there are more than just a handful of cheap stocks making big moves. Look at tech companies like Mmtec Inc. (NASDAQ: MTC). Not only has the penny stock been on an absolute tear over the last few weeks, but shares have also climbed another 60% on Friday.

Overall, MTC stock’s price has rallied more than 400% since last Friday’s close. Now, if you were to look at the overall tech sector in the stock market today or the tech-heavy Nasdaq ETF – QQQ – it’s a night and day difference. The Qs are hovering around their October lows on October 20.

How Global Events are Impacting the Stock Market

Middle East Conflicts Cause Turbulence

Lately, the stock market has been on a rollercoaster ride, reacting to stuff happening around the world. At first, stocks took a dip when the 10-year Treasury yield spiked to 5% before pulling back. Major indexes dropped over 1% as investors got worried about rising yields and earnings reports.

How To Trade Penny Stocks When The Stock Market Is Down

Then, tensions in the Middle East added to everyone’s anxiety, especially with Israel and Hamas fighting and airstrikes happening.​ Oil prices surged because of all this, which affected global markets. Experts say if the U.S. gets involved militarily in the Middle East, we could see oil prices rise by $20 per barrel. This shows how sensitive stocks are to world events.​

In Asia, shares slid amid escalating Middle East conflicts and investors getting risk-averse. Besides stocks, crude and gold prices also went up due to supply concerns and demand for safe havens in case things get worse in Israel and Hamas.​​

Earnings Reports Paint a Mixed Picture

Amidst the worrying world events, the market is also dealing with mixed earnings reports from major companies this quarter. The good and bad news in earnings has sent investors looking for a common thread, as they try to find stability with so much uncertainty both in the U.S. and globally. All this shows the market is in flux, reacting to economic indicators at home and conflicts abroad.

It highlights how connected world markets are, with global events influencing investor sentiment. With such a trend, high-volatility stocks are gaining more attention from short-term traders. Penny stocks have presented interesting prospects. In this article, we look at a handful of cheap stocks under $5 gaining momentum in the stock market today.

Penny Stocks To Buy? 3 To Watch

Penny Stocks to Watch 1. Aravive Inc. (NASDAQ: ARAV)

Shares of Aravive stock have climbed higher for the last few weeks. Prices put in new 52-week lows of 11 cents, and before it became on of the Nasdaq penny stocks under 10 cents, ARAV stock bounced. It continues at the end of the week now up nearly 100% since then.

The company was hit hard in the market after its Phase 3 AAXLerate-OC study missed its primary endpoint in August. Gail McIntyre, Ph.D., DABT, Aravive’s President and Chief Executive Officer responded to the results saying, “We are conducting additional analyses on the AXLerate-OC Phase 3 trial to further evaluate the results of this study and determine the best path forward with our two other planned indications in renal cell carcinoma and pancreatic cancer.”

Although no further communication has come up recently, ARAV stock has gained some speculative interest this week.

Hub Cyber Security (NASDAQ: HUBC)

Hub Cyber is one of the otherwise very quiet penny stocks to watch that exploded recently. There haven’t been any news headlines from the company in weeks and daily volumes were extremely low heading into October.

Making a 2024 Penny Stocks Strategy? 3 Tips

However, with the rise of interest in cybersecurity stocks, cheap stocks like HUBC have gained speculative attention. What does the company do? It isn’t going to be competing with the likes of Palo Alto Networks (NASDAQ: PANW) anytime soon from the look of earnings. This speculation has helped fuel a move that has allowed HUBC stock to far outpace anything PANW stock has done from a percentage-change perspective.

Last month Hub gave a series of updates and plans to further build upon its growth. This included a new line of products to enhance Zero-Trust security for its clients. The company’s flagship Hub Secure File Vault has also undergone a transformation to become more robust for large enterprises and governments.

– Best Penny Stocks To Buy Now? These 3 Are Moving Fast In October

Against this backdrop Uzi Moskowitz, CEO of Hub Security, stated, “These updates represent our unwavering commitment to our clients, investors, and employees. We are navigating these transformative times with resilience and determination, focusing on innovation and financial stability to emerge stronger than ever.”

JetBlue Airways Inc. (NASDAQ: JBLU)

Penny stocks to buy avoid JetBlue Airways JBLU stock

We wrote about JBLU stock (See: Will JetBlue (JBLU) Be On Your List Of Penny Stocks In 2023?) before gracing the penny stock stage and as share prices took a nosedive last quarter. Now, it may seem that some hope for the penny stock to finally take flight.

As share prices rebound, options action has picked up. More than 67,000 contracts of open interest are showing in the 10/20 $5.00 Calls in the stock market today, which is where the bulk of the action appears.

JetBlue recently announced the record and payment dates for October’s prepayment to Spirit stockholders. This is related to the plan of merger with Spirit Airlines. The end of September saw JetBlue announcing it would raise flight attendant pay next year and provide other bonuses, which appealed to the unions. Flight attendants will get 5% raises starting in November. A JetBlue spokesman said, “Because our inflight crewmembers play a significant role in delivering the JetBlue experience, it’s important that we’re able to attract and retain high-quality crewmembers with competitive pay and benefits.”

With this, JBLU stock has slowly clawed back some of its losses over the last month but is still trading significantly lower than in June.

The post Penny Stocks To Buy? Watch These 3 Under $5 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Uncategorized

In Silico Antibody Design: Navigating Latest Trends and Envisioning Future Technologies

In this GEN webinar, Dr. Anne Goupil-Lamy from BIOVIA will discuss how machine learning and AI is accelerating the discovery of novel biotherapeutics,…

Published

on

Broadcast Date: December 13, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Antibodies, as powerful therapeutic agents, have demonstrated immense potential in treating a range of diseases, from cancer to infectious diseases. Recent advances in artificial intelligence (AI) and computational modeling are making it possible to push the boundaries of antibody design and deliver even more effective therapies.

In this GEN webinar, Dr. Anne Goupil-Lamy will discuss how machine learning and AI is accelerating the discovery of novel biotherapeutics, including antibodies. During the webinar, she will showcase cutting-edge computational techniques for epitope mapping, affinity maturation, and humanization while ensuring compatibility for therapeutic use. She will also discuss techniques for assessment of antibody developability, including aggregation, solubility, viscosity, and excipient formulation to enhance candidate success.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

Anne Goupil-Lamy, PhD
Principal Field Application Scientist and Science Council Fellow
BIOVIA

 

The post In Silico Antibody Design: Navigating Latest Trends and Envisioning Future Technologies appeared first on GEN - Genetic Engineering and Biotechnology News.

Read More

Continue Reading

Trending